A phase II, open-label evaluation of cysteamine tolerability in patients with Huntington's disease.
Identifieur interne : 000345 ( Main/Exploration ); précédent : 000344; suivant : 000346A phase II, open-label evaluation of cysteamine tolerability in patients with Huntington's disease.
Auteurs : Adriana Prundean [France] ; Katia Youssov ; Sandrine Humbert ; Dominique Bonneau ; Christophe VernySource :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2015.
English descriptors
- KwdEn :
- MESH :
- chemical , administration & dosage : Cysteamine.
- chemical , adverse effects : Cysteamine.
- chemical , therapeutic use : Cysteamine.
- drug therapy : Huntington Disease.
- Adolescent, Adult, Drug Tolerance, Humans, Middle Aged, Treatment Outcome, Young Adult.
DOI: 10.1002/mds.26101
PubMed: 25475049
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000333
- to stream PubMed, to step Curation: 000333
- to stream PubMed, to step Checkpoint: 000346
- to stream Ncbi, to step Merge: 004176
- to stream Ncbi, to step Curation: 004176
- to stream Ncbi, to step Checkpoint: 004176
- to stream Main, to step Merge: 000345
- to stream Main, to step Curation: 000345
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A phase II, open-label evaluation of cysteamine tolerability in patients with Huntington's disease.</title><author><name sortKey="Prundean, Adriana" sort="Prundean, Adriana" uniqKey="Prundean A" first="Adriana" last="Prundean">Adriana Prundean</name><affiliation wicri:level="1"><nlm:affiliation>Centre de référence des maladies neurogénétiques, Centre Hospitalier Universitaire, Angers, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Centre de référence des maladies neurogénétiques, Centre Hospitalier Universitaire, Angers</wicri:regionArea><placeName><settlement type="city">Angers</settlement></placeName></affiliation></author><author><name sortKey="Youssov, Katia" sort="Youssov, Katia" uniqKey="Youssov K" first="Katia" last="Youssov">Katia Youssov</name></author><author><name sortKey="Humbert, Sandrine" sort="Humbert, Sandrine" uniqKey="Humbert S" first="Sandrine" last="Humbert">Sandrine Humbert</name></author><author><name sortKey="Bonneau, Dominique" sort="Bonneau, Dominique" uniqKey="Bonneau D" first="Dominique" last="Bonneau">Dominique Bonneau</name></author><author><name sortKey="Verny, Christophe" sort="Verny, Christophe" uniqKey="Verny C" first="Christophe" last="Verny">Christophe Verny</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25475049</idno><idno type="pmid">25475049</idno><idno type="doi">10.1002/mds.26101</idno><idno type="wicri:Area/PubMed/Corpus">000333</idno><idno type="wicri:Area/PubMed/Curation">000333</idno><idno type="wicri:Area/PubMed/Checkpoint">000346</idno><idno type="wicri:Area/Ncbi/Merge">004176</idno><idno type="wicri:Area/Ncbi/Curation">004176</idno><idno type="wicri:Area/Ncbi/Checkpoint">004176</idno><idno type="wicri:Area/Main/Merge">000345</idno><idno type="wicri:Area/Main/Curation">000345</idno><idno type="wicri:Area/Main/Exploration">000345</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">A phase II, open-label evaluation of cysteamine tolerability in patients with Huntington's disease.</title><author><name sortKey="Prundean, Adriana" sort="Prundean, Adriana" uniqKey="Prundean A" first="Adriana" last="Prundean">Adriana Prundean</name><affiliation wicri:level="1"><nlm:affiliation>Centre de référence des maladies neurogénétiques, Centre Hospitalier Universitaire, Angers, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Centre de référence des maladies neurogénétiques, Centre Hospitalier Universitaire, Angers</wicri:regionArea><placeName><settlement type="city">Angers</settlement></placeName></affiliation></author><author><name sortKey="Youssov, Katia" sort="Youssov, Katia" uniqKey="Youssov K" first="Katia" last="Youssov">Katia Youssov</name></author><author><name sortKey="Humbert, Sandrine" sort="Humbert, Sandrine" uniqKey="Humbert S" first="Sandrine" last="Humbert">Sandrine Humbert</name></author><author><name sortKey="Bonneau, Dominique" sort="Bonneau, Dominique" uniqKey="Bonneau D" first="Dominique" last="Bonneau">Dominique Bonneau</name></author><author><name sortKey="Verny, Christophe" sort="Verny, Christophe" uniqKey="Verny C" first="Christophe" last="Verny">Christophe Verny</name></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="eISSN">1531-8257</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Cysteamine (administration & dosage)</term><term>Cysteamine (adverse effects)</term><term>Cysteamine (therapeutic use)</term><term>Drug Tolerance</term><term>Humans</term><term>Huntington Disease (drug therapy)</term><term>Middle Aged</term><term>Treatment Outcome</term><term>Young Adult</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Cysteamine</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Cysteamine</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Cysteamine</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Huntington Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Drug Tolerance</term><term>Humans</term><term>Middle Aged</term><term>Treatment Outcome</term><term>Young Adult</term></keywords></textClass></profileDesc></teiHeader></TEI><affiliations><list><country><li>France</li></country><settlement><li>Angers</li></settlement></list><tree><noCountry><name sortKey="Bonneau, Dominique" sort="Bonneau, Dominique" uniqKey="Bonneau D" first="Dominique" last="Bonneau">Dominique Bonneau</name><name sortKey="Humbert, Sandrine" sort="Humbert, Sandrine" uniqKey="Humbert S" first="Sandrine" last="Humbert">Sandrine Humbert</name><name sortKey="Verny, Christophe" sort="Verny, Christophe" uniqKey="Verny C" first="Christophe" last="Verny">Christophe Verny</name><name sortKey="Youssov, Katia" sort="Youssov, Katia" uniqKey="Youssov K" first="Katia" last="Youssov">Katia Youssov</name></noCountry><country name="France"><noRegion><name sortKey="Prundean, Adriana" sort="Prundean, Adriana" uniqKey="Prundean A" first="Adriana" last="Prundean">Adriana Prundean</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000345 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000345 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:25475049
|texte= A phase II, open-label evaluation of cysteamine tolerability in patients with Huntington's disease.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25475049" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a MovDisordV3
| This area was generated with Dilib version V0.6.23. |  |